Blackford and b-rayZ Partner to Bring AI powered Breast Cancer Solutions to Healthcare Providers
20 févr. 2024 05h30 HE
|
Blackford
Blackford and b-rayZ Partner to Bring AI powered Breast Cancer Solutions to Healthcare Providers
Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer
06 févr. 2024 06h45 HE
|
Arvinas Inc.
-- Vepdegestrant is an investigational PROteolysis Targeting Chimera (PROTAC®) protein degrader designed to target and degrade the estrogen receptor (ER) protein -- NEW HAVEN, Conn. and NEW YORK,...
Arvinas to Present at 6th Annual Guggenheim Biotechnology Conference
01 févr. 2024 16h30 HE
|
Arvinas Inc.
NEW HAVEN, Conn., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Europe Next-Generation Breast Cancer Diagnostic and Screening Market Analysis 2023-2032: Enhancing Early Detection and Personalized Care
25 janv. 2024 11h00 HE
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Europe Next-Generation Breast Cancer Diagnostic and Screening Market: Analysis and Forecast, 2023-2032" report has been added to ...
Italy Breast Cancer Diagnostics Market Sees Major Advancements and Strategic Approaches in 2024, Fueled by Emerging Technologies
25 janv. 2024 09h27 HE
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "2024 Italy Breast Cancer Diagnostics Market - Country Database and Analysis - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment...
2024 Latin America Breast Cancer Diagnostics Market: 22-Country Database and Analysis, Supplier Shares and Strategies, Emerging Technologies, Latest Instrumentation & Growth Opportunities
24 janv. 2024 05h25 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "2024 Latin America Breast Cancer Diagnostics Market - A 22-Country Database and Analysis, 2023 Supplier Shares and Strategies, 2023-2028 Volume and...
Oncology Nutrition Market Experiences Growth with Rise in Personalized and Immuno-nutrition Trends
22 janv. 2024 21h28 HE
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Oncology Nutrition Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The recent comprehensive analysis within...
Oncology Devices Market Set for Robust Expansion, with AI Innovations and Advancements in Radiation Therapy Techniques
22 janv. 2024 21h18 HE
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Oncology Devices Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global oncology devices market is...
Anti-Cancer Monoclonal Antibodies Market to Reach $95.99 billion by 2028, with Asia Pacific Emerging as Fastest-Growing Region
22 janv. 2024 21h08 HE
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Anti-Cancer MAbS Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The Anti-Cancer Monoclonal Antibodies (MAbs)...
Arvinas Appoints Jared Freedberg as General Counsel
16 janv. 2024 17h01 HE
|
Arvinas Inc.
NEW HAVEN, Conn., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...